Controversies in ophthalmology

Article

The full scientific programme for the March Congress is now available.

Macular surgery, whether to peel or not to peel the internal limiting membrane, surgical management of various macular pathologies, the effect of catarct on diabetic retinopathy and controversial cases in retinal detachment are just some of the headlines from the Scientific Programme of the World Congress on Controversies in Ophthalmology, which takes place in March in Prague.

The event is intended as forum for international experts to share and compare experiences in order to outline the potentially best treatments for patients within controversial areas. There is little available in the peer-reviewed literature on controversies in Ophthalmology, so there is a perceived need to enable an effective debate about unresolved issues, often resulting in agreed-upon answers supported by evidence-based medicine and expert opinion.

Participants will have the advantage of discussing and debating these unresolved issues with leading world experts in all fields of Ophthalmology. The Congress aims to reach the best answers currently possible and provide the clinician with reliable, up-to-date scientific solutions, based on the best existing evidence.

Members of OTEurope's Editorial Advisory Board will be chairing some of the debates.

To get the full programme click here

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.